Air Nicotine and Saliva Cotinine as Indicators of Workplace Passive Smoking Exposure and Risk  1 | Zendy

Repace James L. | Zendy; Jinot Jennifer | Zendy; Bayard Steven | Zendy; Emmons Karen | Zendy; Hammond S. Katharine | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Air Nicotine and Saliva Cotinine as Indicators of Workplace Passive Smoking Exposure and Risk 1

Author(s) -

Repace James L.,

Jinot Jennifer,

Bayard Steven,

Emmons Karen,

Hammond S. Katharine

Publication year - 1998

Publication title -

risk analysis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.972

H-Index - 130

eISSN - 1539-6924

pISSN - 0272-4332

DOI - 10.1111/j.1539-6924.1998.tb00917.x

Subject(s) - cotinine , tobacco smoke , environmental health , medicine , lung cancer , nicotine , passive smoking , occupational exposure , heart disease , demography , sociology

We model nicotine from environmental tobacco smoke (ETS) in office air and salivary cotinine in nonsmoking U.S. workers. We estimate that: an average salivary cotinine level of 0.4 ng/ml corresponds to an increased lifetime mortality risk of 1/1000 for lung cancer, and 1/100 for heart disease; >95% of ETS‐exposed office workers exceed OSHA's significant risk level for heart disease mortality, and 60% exceed significant risk for lung cancer mortality; 4000 heart disease deaths and 400 lung cancer deaths occur annually among office workers from passive smoking in the workplace, at the current 28% prevalence of unrestricted smoking in the office workplace.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research